Preclinical and clinical studies evaluating MAK in relation to atherosclerosis, angina, ischemic heart disease, plaque formation, and other relevant cardiovascular outcomes were screened using predefined inclusion and exclusion criteria.<h4>Results</h4>Out of 82 identified records, 13 studies met the inclusion criteria. This evidence concerns the gene MAK and coronary artery disorder.